Mount Sinai Health System
As an interventional surgeon, Dr. Tang has performed >4000 structural heart interventions (including >600 mitral and tricuspid procedures) and is a world expert in the lifetime management after TAVR (redo TAVR and TAVR explant), transcatheter mitral and tricuspid interventions, and 3D intracardiac echo. Dr. Tang has pioneered several techniques in TAVR that have become the standard practice. He serves on committees in the Heart Valve Collaboratory, PCR, and several clinical trials, and is the Principal Investigator in the global EXPLANT-TAVR, EXPLANTORREDO-TAVR, and CUTTING-EDGE registries. Dr. Tang is the Editor-in-Chief for JACC Case Reports, a 4-time recipient of the Simon Dack Award for JACC, a FRCSC, FACC and the first surgeon to be a FSCAI, as well as a member of the AATS, STS and AHA. He has published >200 articles, lectured and trained many heart teams around the world, owns a YouTube channel and has >19,000 followers on Twitter/X and Linkedin. Dr. Tang obtained his BA from Harvard University and MD from University of Toronto. Dr. Tang completed his cardiac surgery residency training at the University of Toronto and also a Masters of Science there and an MBA at Harvard.
Disclosure(s): Abbott Structural Heart: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing); JenaValva: Consultant/Advisory Board (Terminated, December 31, 2022); Medtronic: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); NeoChord: Consultant/Advisory Board (Terminated, December 31, 2022); Peija Medical: Consultant/Advisory Board (Ongoing); Shenqi Medical Technology: Consultant/Advisory Board (Ongoing); Shockwave Medical: Consultant/Advisory Board (Ongoing); Siemens Healthineers: Speaker/Honoraria (Ongoing)
352 - TRICUSPID VALVE: THE NOW LESS FORGOTTEN VALVE FOR SURGEONS AND CARDIOLOGISTS
Saturday, October 26, 2024
3:30 PM – 3:45 PM PT